Proactive Investors - Run By Investors For Investors

Fertoz a leading ASX gainer with shares up almost 40%

The company’s shares today reached a new 12-month high of 26.5 cents.
ASX chart with arrow pointing up
Fertoz markets and develops organic fertiliser products

Fertoz Ltd (ASX:FTZ), which markets and develops organic fertiliser products, is a leading ASX gainer today, up almost 40% to a new 12-month high of 26.5 cents.

This month the company received the BioGro New Zealand Certificate of Compliance for its leading organic fertiliser FertAg 0-8-0.

READ: Fertoz’s organic fertiliser certified as genuine organic product in New Zealand

BioGro is New Zealand’s largest and best-known certifier for organic produce and products, certifying and accrediting more than 750 producers, farmers and manufacturers across New Zealand and the Pacific.

The BioGro logo guarantees that a product is made without animal testing, genetic modification and the routine use of synthetic pesticides.

It is the mark of a genuine organic product, and FertAg 0-8-0 is now certified for organic agriculture in Australia and New Zealand.

READ: Fertoz shareholders approve board appointment of Stuart Richardson

New Zealand represents a large potential market for FertAg 0-8-0 as many areas have soils that are suffering from mineral and phosphate depletion.

FertAg, the company’s wholly owned Australian subsidiary, is in discussions with various distributors in New Zealand with some having already begun placing orders.

The company is also working with cannabis producers to position itself as a credible source of reliable agronomic information and a premium supplier of organic fertilisers for cannabis plants.

View full FTZ profile View Profile

Fertoz Ltd Timeline

Related Articles

Australian dollars
September 28 2018
The company is now achieving positive earnings before interest, tax, depreciation and amortisation results each month.
VR booth
July 12 2018
“We want to move very quickly. We see it is a landgrab opportunity"
Mergers and acquisitions graphic
Swift’s investors will vote on its planned acquisition of ad specialist Medical Media.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use